Product Name :
Ac-RYYRIK-NH2
Description:
Ac-RYYRIK-NH2 is a potent and partial agonist on ORL1 transfected in CHO cells (Kd=1.5 nM) and behaves as a endogenous ligand of ORL1. Ac-RYYRIK-NH2 is a specific antagonist for the activation of G protein and competitively antagonizes the stimulation of [35S]-GTPgS binding to G proteins by nociceptin/orphanin FQ (noc/OFQ) in membranes and sections of rat brain.
CAS:
200959-48-4
Molecular Weight:
939.12
Formula:
C44H70N14O9
Chemical Name:
(2S)-6-amino-2-[(2S,3S)-2-[(2S)-5-[(diaminomethylidene)amino]-2-[(2S)-2-[(2S)-2-[(2S)-5-[(diaminomethylidene)amino]-2-acetamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]pentanamido]-3-methylpentanamido]hexanamide
Smiles :
CC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1C=CC(O)=CC=1)C(=O)N[C@@H](CC1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O
InChiKey:
WBBBVZGQADABSU-RERZDIOCSA-N
InChi :
InChI=1S/C44H70N14O9/c1-4-25(2)36(42(67)54-31(37(46)62)9-5-6-20-45)58-39(64)33(11-8-22-52-44(49)50)55-40(65)34(23-27-12-16-29(60)17-13-27)57-41(66)35(24-28-14-18-30(61)19-15-28)56-38(63)32(53-26(3)59)10-7-21-51-43(47)48/h12-19,25,31-36,60-61H,4-11,20-24,45H2,1-3H3,(H2,46,62)(H,53,59)(H,54,67)(H,55,65)(H,56,63)(H,57,66)(H,58,64)(H4,47,48,51)(H4,49,50,52)/t25-,31-,32-,33-,34-,35-,36-/m0/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Disulfiram} web|{Disulfiram} Metabolic Enzyme/Protease|{Disulfiram} Purity & Documentation|{Disulfiram} Data Sheet|{Disulfiram} custom synthesis|{Disulfiram} Autophagy}
Shelf Life:
≥12 months if stored properly.{{Nicotinamide riboside} web|{Nicotinamide riboside} Cell Cycle/DNA Damage|{Nicotinamide riboside} Purity & Documentation|{Nicotinamide riboside} In stock|{Nicotinamide riboside} manufacturer|{Nicotinamide riboside} Cancer}
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Ac-RYYRIK-NH2 is a potent and partial agonist on ORL1 transfected in CHO cells (Kd=1.5 nM) and behaves as a endogenous ligand of ORL1. Ac-RYYRIK-NH2 is a specific antagonist for the activation of G protein and competitively antagonizes the stimulation of [35S]-GTPgS binding to G proteins by nociceptin/orphanin FQ (noc/OFQ) in membranes and sections of rat brain.|Product information|CAS Number: 200959-48-4|Molecular Weight: 939.12|Formula: C44H70N14O9|Chemical Name: (2S)-6-amino-2-[(2S,3S)-2-[(2S)-5-[(diaminomethylidene)amino]-2-[(2S)-2-[(2S)-2-[(2S)-5-[(diaminomethylidene)amino]-2-acetamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]pentanamido]-3-methylpentanamido]hexanamide|Smiles: CC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1C=CC(O)=CC=1)C(=O)N[C@@H](CC1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(N)=O|InChiKey: WBBBVZGQADABSU-RERZDIOCSA-N|InChi: InChI=1S/C44H70N14O9/c1-4-25(2)36(42(67)54-31(37(46)62)9-5-6-20-45)58-39(64)33(11-8-22-52-44(49)50)55-40(65)34(23-27-12-16-29(60)17-13-27)57-41(66)35(24-28-14-18-30(61)19-15-28)56-38(63)32(53-26(3)59)10-7-21-51-43(47)48/h12-19,25,31-36,60-61H,4-11,20-24,45H2,1-3H3,(H2,46,62)(H,53,59)(H,54,67)(H,55,65)(H,56,63)(H,57,66)(H,58,64)(H4,47,48,51)(H4,49,50,52)/t25-,31-,32-,33-,34-,35-,36-/m0/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.PMID:23991096 |Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vivo:|Ac-RYYRIK-NH2 (intracerebroventricularly (i.c.v.) inhibits spontaneous locomotor activity in mice with an ID50 of 0.07 nmol. Co-administration of noc/OFQ and Ac-RYYRIK-NH2 lead to additive effects in Male Swiss mice.|Products are for research use only. Not for human use.|
